| Line Item | 2025-11-02 | Y/Y |
|---|---|---|
| Revenue | $63.89B | +23.9% |
| Cost of Revenue | $20.59B | +8.0% |
| Gross Profit | $43.29B | +33.2% |
| R&D Expense | $10.98B | +17.9% |
| SG&A Expense | $4.21B | -15.1% |
| Operating Income | $25.48B | +89.3% |
| Pre-tax Income | $22.73B | +129.2% |
| Income Tax | -$397.0M | -110.6% |
| Net Income | $23.13B |
| Line Item | 2025-11-02 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.18B | +73.1% |
| Accounts Receivable | $7.14B | +61.8% |
| Inventory | $2.27B | +29.0% |
| Current Assets | $31.57B | +61.1% |
| Total Assets | $171.09B | +3.3% |
| Current Liabilities | $18.51B | +10.9% |
| Long-term Debt | $61.98B | -6.5% |
| Line Item | 2025-11-02 | Y/Y |
|---|---|---|
| Operating Cash Flow | $27.54B | +37.9% |
| Capital Expenditures | $623.0M | +13.7% |
| Investing Cash Flow | -$580.0M | +97.5% |
| Financing Cash Flow | -$20.13B | -1061.4% |
| Free Cash Flow | $26.91B | +38.6% |
| +292.3% |
| EPS (Basic) | $4.91 | +286.6% |
| EPS (Diluted) | $4.77 | +287.8% |
| Total Liabilities |
| $89.80B |
| -8.3% |
| Stockholders' Equity | $81.29B | +20.1% |